Results showed a high risk of cancer recurrence (relapse risk score 59), with a low probability of pCR (pCR likelihood score 11) and low ERBB2 expression (ERBB2 mRNA level score 20), consistently with the previous IHC/FISH borderline result. Here, ERBB2 is linked to cancer.